Pfizer has reportedly matched Novo Nordisk’s (NVO) offer to buy weight-loss drug start-up Metsera (MTSR) for up to $10 ...
Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big ...
A regenerative medicine company will open a headquarters office in Boca that includes manufacturing and distribution ...
Pfizer and Novo Nordisk are in a takeover clash over the obesity biotech Metsera, while some House Republicans warm to ...
Metsera on Tuesday called Novo Nordisk’s new $10 billion offer “superior” to rival Pfizer's bid of $8 billion.
Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...
How much would you pay to never have to say goodbye to a beloved pet? If you've got enough cash, you might be able to.
A Boston biotech has signed a deal with Roche potentially worth over $2 billion to create multiple "shuttles" that can bring ...
Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 ...
Evaxion Biotech (NASDAQ: EVAX) is set to give its latest quarterly earnings report on Thursday, 2025-11-06. Here's what ...
24/7 Wall St. on MSN
Insiders Scoop Up Shares of This Biotech IPO, Energy Giant, and More
In the past week or so, a biotech and an energy infrastructure giant saw some huge insider buying. These were not the only ...
Investors have once again turned to Chinese pharmaceutical company Jiangsu Hengrui to create a new biotech startup, this time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results